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Abstract
Knockdown of T-cell intracellular antigens TIA1 and TIAR contributes to a cellular phenotype characterised by uncontrolled
proliferation and tumorigenesis. Massive-scale poly(A+) RNA sequencing of TIA1 or TIAR-knocked down HeLa cells reveals
transcriptome signatures comprising genes and functional categories potentially able to modulate several aspects of
membrane dynamics associated with extracellular matrix and focal/cell adhesion events. The transcriptomic heterogeneity
is the result of differentially expressed genes and RNA isoforms generated by alternative splicing and/or promoter usage.
These results suggest a role for TIA proteins in the regulation and/or modulation of cellular homeostasis related to focal/cell
adhesion, extracellular matrix and membrane and cytoskeleton dynamics.
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Introduction
T-cell intracellular antigen 1 (TIA1) and TIA1 related/like
(TIAR/TIAL1) are two proteins that impact several molecular
aspects of RNA metabolism at different transcriptional and post-
transcriptional layers of gene expression [1–4]. In the nucleus, TIA
proteins regulate and/or modulate DNA-dependent transcription
by interacting with DNA and RNA polymerase II [5–8]. Also, they
facilitate splicing of pre-mRNAs (around 10–20% of splicing
events in human genome) via improving the selection of
constitutive and atypical 59 splice sites through shortening the
time available for definition of an exon by enhancing recognition
of the 59 splice sites [9–12]. In the cytoplasm, they regulate and/or
modulate localization, stability and/or translation of human
mRNAs by binding to the 59 and/or 39 untranslatable regions
[13–25]. Therefore, these multifunctional proteins impress prev-
alently on the molecular and cellular biology of specific RNAs and
proteins, altering their lives and destinies in response to
environmental cues and challenges.
TIA proteins appear to have a pleiotropic role in the control of
cell physiology. For example, they have been shown to play an
important role during embryogenesis. Accordingly, mice lacking
TIA1 and TIAR die before embryonic day 7, indicating that one
or both proteins must be properly expressed for normal early
embryonic development. Indeed, mice lacking TIA1 or TIAR, or
ectopically over-expressing TIAR, show higher rates of embryonic
lethality [17,26–28]. Further, TIA regulators are known to target
genes with relevant biological associations with cell networks
involving complex responses such as death/survival, proliferation/
differentiation, inflammation, adaptation to environmental stress,
viral infections and tumorigenesis [1,2,13–28].
Although the relevance of TIA proteins in key cellular processes
involving, for example, inflammation and the stress responses, are
well established, their roles on proliferation/differentiation events
and survival/cell death responses in patho-physiological settings
are not completely known. To assess the potential long-term
regulatory roles of TIA proteins in cellular responses, we used an
RNA interference strategy to stably down-regulate TIA1/TIAR
expression together with genome-wide profiling analysis, to
identify genes and processes involved in cell phenotypes regulated
and/or modulated by TIA proteins. Our findings suggest that TIA
proteins regulate and/or modulate membrane dynamics linked to
extracellular matrix and focal/cell adhesion components.
Materials and Methods
Cell cultures and immunofluorescence analysis
Adherent HeLa cell lines, silenced for expression of TIA1,
TIAR and HuR, or control cells, were constructed by stable
transfection of corresponding short hairpin RNAs (shRNAs) (Fig.
S1). Cell lines were maintained under standard conditions and
analyzed by confocal microscopy [23–25].
RNA purification
Total RNA was purified with TRIzol Reagent (Invitrogen).
RNA quality was assessed using the Agilent 2100 Bioanalyzer.
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Library preparation and sequencing
cDNA libraries were prepared with Illumina’s mRNA-Seq
Sample Prep kit following the manufacturer’s protocol. Each
library was run on one RNASeq Multiplexed 75-bp paired-end
sequence using the Illumina Genome Analyzer (GAIIx), facilitated
by the Madrid Science Park.
Primary processing of Illumina RNA-seq reads
RNA-seq reads were obtained using Bustard (Illumina Pipeline
version 1.3). Reads were quality-filtered using the standard
Illumina process. Three sequence files were generated in FASTQ
format; each file corresponded to the HeLa cell line from which
the RNA originated [29]. The total number of reads and
additional metrical data are shown in Fig. S2. The sequence data
have been deposited in the NCBI Gene Expression Omnibus
database (http://www.ncbi.nlm.nih.gov/geo/info/linking.html)
and are accessible through the GEO Series accession number
GSE46516.
Mapping of RNA-seq reads using TopHat
Reads were processed and aligned to the University of
California, Santa Cruz, reference human genome (UCSC, build
hg19) using the TopHat tool [30].
Transcript assembly and abundance estimation using
Cufflinks
The aligned read files were processed using the Cufflinks
software suite [31]. Cufflinks uses the normalized RNA-seq
fragment counts to measure the relative abundance of transcripts.
The unit of measurements is fragments per kilobase of exon per
million fragments mapped (FPKM). Confidence intervals for
FPKM estimates were calculated using Bayesian inference [32].
Comparison of reference annotation and differential
expression testing using Cuffcompare and Cuffdiff
Once all short read sequences were assembled with Cufflinks,
the output. GTF files were sent to Cuffcompare along with a
reference. GTF annotation file downloaded from the Ensembl
database. This classified each transcript as known or novel.
Cuffcompare produces a combined. GTF file which is passed to
the Cuffdiff tool with the original alignment (.SAM) files produced
by TopHat. We used Cuffdiff to perform two pairwise compar-
isons of expression, splicing and promoter use between control,
TIA1 or TIAR-silenced samples.
Visualization of mapped reads
Mapping results were visualized using both the UCSC genome
browser [33,34] and the Integrative Genomics Viewer software,
available at http://www.broadinstitute.org/igv/. Views of indi-
vidual genes were generated by uploading coverage.wig files to the
UCSC Genome browser as a custom track. Data files were
restricted to the chromosome in question due to upload limits
imposed by the genome browser. The same method was used to
generate coverage plots for all chromosomes.
Genome-wide profiling by microarray analysis
RNA quality checks, amplification, labelling, hybridization with
Human Genome U133 Plus 2.0 Array Chips (approximately
55,000 transcripts) (Affymetrix Inc. Santa Clara, CA) and initial
data extraction were performed at the Genomic Service Facility at
the Centro Nacional de Biotecnologı´a (CNB-CSIC). Comparison
of multiple cDNA array images (three independent experiments
per each biological condition tested) was carried out by using an
average of all of the gene signals on the array (global
normalization) to normalize the signal between arrays. The
quantified signals were background-corrected (local background
subtraction) and normalized using the global Lowess (LOcally
WEighted Scatterplot Smoothing) regression algorithm. Local
background was corrected by the normexp method with an offset
of 50. Background-corrected intensities were transformed to log
scale (base 2) and normalized by Lowess for each array [35].
Finally, to obtain similar intensity distribution across all arrays,
Lowess-normalized-intensity values were scaled by adjusting their
quantiles [36]. After data processing, each probe was tested for
changes in expression over replicates using an empirical Bayes
moderated t statistic [37]. To control the false discovery rate
(FDR), P values were corrected using the method of Benjamini
and Hochberg [38]. FIESTA viewer (http://bioinfogp.cnb.csic.
es/tools/ FIESTA) was used to visualize all microarray results and
to evaluate the numerical thresholds (–1.5$ fold change $1.5;
FDR,0.05) applied for selecting differentially expressed genes
[39]. Microarray data have been deposited in the NCBI Gene
Expression Omnibus database (http://www.ncbi.nlm.nih.gov/
geo/info/ linking.html) and are accessible through the GEO
Series accession number GSE47664.
Functional analysis of gene lists
The Gene Ontology (GO) and Kyoto Encyclopedia of Genes
and Genomes (KEGG) database analyses were conducted using
software programmes provided by GenCodis3 (http://genecodis.
cnb.csic.es) [40,41]. The functional clustering tools were used to
look for functional enrichment for significantly over- and under-
expressed genes (P,0.05) in control, TIA and/or TIAR-silenced
HeLa cell lines.
QPCR analysis
Reverse transcription (RT) reactions and real-time polymerase
chain reaction (PCR) was performed at the Genomic PCR Core
Facility at Universidad Auto´noma de Madrid in the Centre of
Molecular Biology Severo Ochoa. Analysis was performed on two
independent samples in triplicate, including no-template and RT-
minus controls. Beta-actin (ACTB) mRNA expression was used as
an endogenous reference control. Relative mRNA expression was
calculated using the comparative cycle threshold method. The
primer pairs used in the analysis are described in Fig. S8. The
following mRNAs were quantified: TIA1, T-cell intracellular
antigen 1; TIAR, TIA1 related protein; ACTB; beta-actin;
CLGN, calmegin; COL1A2, collagen type 1, alpha 2; FAM129A,
cell growth inhibiting protein 39; FBN2, fibrillin 2; LGR5, leucine-
rich repeat containing G protein-coupled receptor 5; MKX,
mohawk homeobox; TWIST1, twist basic helix-loop-helix;
AKR1C1-4, aldo-keto reductase family, members C1–C4;
CCL2, chemokine (C-C motif) ligand 2; COL4A4, collagen type
IV, alpha 4; COL5A3, collagen type V, alpha 3; OSGIN1,
oxidative stress induced growth inhibitor 1 and TNFRF11B,
tumor necrosis factor receptor superfamily member 11b.
Fluorescence microscopy
Control and TIA-silenced HeLa cells were grown for 24 h on
coverslips, washed with phosphate-buffered saline (PBS), fixed in
formalin (Sigma) at room temperature for 10 min, washed with
PBS, and processed. For immunofluorescence, the coverslips were
incubated for 45 min at room temperature with the primary
antibodies against TIA1, TIAR, HuR (Santa Cruz Biotechnology)
or a-tubulin (Sigma) proteins [23,24]. The samples were then
washed with PBS and incubated for 45 min with the correspond-
ing secondary antibodies (Invitrogen). The samples were then
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washed in PBS and mounted with Mowiol (Calbiochem).
Microscopy was performed with a confocal microscope.
Cell adhesion assays
A cell adhesion assay was carried out as described [42]. Briefly,
control and TIA-silenced HeLa cells were exponentially grown in
DMEM supplemented with 10% FBS (Sigma). Cells were
deprived of serum for 12 h prior to the assay and then were
washed three times with serum-free DMEM and grown in
DMEM. Cells were detached using 10 mM EDTA and observed
under a microscope to confirm complete dissociation (aprox. 10
min.). The cells were then washed twice with DMEM to remove
EDTA and were resuspended at 26105 cells/ml in DMEM/0.1%
BSA in 12-well plates coated with either BSA (10 mg/ml), rat
collagen I (150 mg/ml) or non-coated. Cells (500 ml) were allowed
to adhere for 20 min at 37uC. Then, each well was washed (four
times) with 300 ml DMEM to eliminate non-adherent cells. After
washing, DMEM containing 10% FBS was added and cells were
allowed to recover at 37uC for 4 h. Following this, 30 ml of MTT
substrate (5 mg/ml) was added to each well and the incubation
was continued for an additional 2 h at 37uC. Finally, the MTT-
treated cells were lysed in buffer containing 10% SDS and 0.03%
HCl and the absorbance was measured at 570 nm on a
spectrophotometer. Where indicated, cells were cultured in the
presence of DMSO or PMA (100 nM) for 4 h and assayed for
MTT activity.
Transfections and luciferase assays
The human COL1A2 promoter construct containing the partial
promoter sequence fused to a firefly luciferase (Luc) reporter gene
was generated as previously described [43]. This construct was
kindly provided by Prof. Miyazahi (Tokyo Medical University,
Tokyo, Japan). Control, TIA1 and/or TIAR-silenced HeLa cells
were transiently co-transfected with 500 ng of pEGFP-C1 and
firefly luciferase reporter plasmids. Cells were incubated at 37uC
for 24 h and lysed with 200 ml of cell culture lysis reagent
(Promega) and microcentrifugated at 14,000 rpm for 5 minutes at
4uC; supernatant was used to determine firefly luciferase activity in
a Monolight 2010 luminometer (Analytical Luminiscence Labo-
ratory). Luciferase activity was expressed as relative light units
(RLU) per milligram of protein and normalized to GFP expression
determined by immunoblot. Co-transfection experiments were
performed in duplicate and the data presented as the means of the
ratio RLU/GFP, expressed as fold induction relative to the




To study the individual contribution of TIA1 and TIAR
proteins on a genome-wide basis, we set out to characterize the
transcriptomes associated with TIA1 or TIAR-down-regulation in
HeLa cells ([25] and Fig. S1). Three transcriptomic libraries were
generated from poly(A+) RNAs isolated from control, TIA1 or
Figure 1. Characterization by massive poly(A+) sequencing of the transcriptomes associated with TIA1 or TIAR-silenced HeLa cells.
(A) Workflow followed to analyze the data from massive-scale poly(A+) RNA sequencing. (B and C) Transcriptional profiling in human chromosomes.
The RNA-seq read density along the length of the human genome (B) and chromosome 1 (C) are shown. (D–H) Venn diagrams displaying
distributions and numbers of differentially-expressed genes (D), genes with isoforms (E), RNA isoforms (F), promoters (G) and microRNAs (H) in TIA1
or TIAR-silenced HeLa cells. The numbers of genes that were up- (in red) and down- (in green) regulated, as well as those shared, are indicated.
doi:10.1371/journal.pone.0113141.g001
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TIAR-knocked down HeLa cells, and were analyzed using the
Illumina platform. The alignment and annotation of resulting
reads, splice junctions and profiles of differentially-expressed
RNAs were performed with bioinformatic tools indicated in
Fig. 1A [29]. A total of 67.37 M reads were obtained from control,
TIA1 and TIAR-silenced cells (Fig. S2). Unique reads were
mapped to the Homo sapiens genome for each condition. The
distribution of mapped reads to different chromosomal features
revealed that a significantly large number (46.3%, 46.4% and
47.9%, respectively) of the reads mapped within mRNA coding
regions. The remaining reads were mapped within untranslated
(UTR) (23.6%, 23.8% and 23.3%, respectively), intronic (11.8%,
11.9% and 11.9%, respectively) and intergenic (18.1%, 17.8% and
16.7%, respectively) regions (Fig. 1B and Fig. S2).
To investigate the level and uniformity of the read coverage
against the human genome, we plotted mapped reads of the
control, TIA1 and TIAR samples along the human genome as
well as for each human chromosome (Fig. S3). The coverage of the
RNA-seq analysis on the human genome was extensive, as
illustrated by chromosome 1 since this is the largest chromosome
in the human karyotype, encoding over 13.6% of all human genes.
As expected, no reads mapped to the centromeres but revealed
extensive transcriptional activity throughout the chromosomes
(Fig. 1B and C and Fig. S3). The distribution of reads within
distinct chromosomal regions indicated a very homogeneous
scattering among the experimental situations compared (Fig. 1B
and C and Fig. S3). Between 91% (corresponding to control
sample) and 92% (corresponding to both TIA1 and TIAR
samples) of reads aligned to the reference genome in a unique
manner. Due to low quality, a small percentage of reads were
removed from the analysis prior to mapping to the reference (Fig.
S2 and S3).
Analysis of differentially expressed genes (DEGs), genes
with isoforms, RNA isoforms, promoters and microRNAs
Cufflinks uses the Cuffdiff algorithm to calculate differential
expression at both the gene and transcript level ([29] and Fig. 1A).
Differential gene expression for control versus TIA1 or TIAR
samples was calculated using the ratio of TIA1 or TIAR versus
control FPKM values for every gene. The differential gene
expression ratios were tested for statistical significance as described
[29]. To detect transcriptional regulation, RNA-seq data was
analyzed by Cufflinks. Cufflinks also identifies post-transcriptional
regulation by looking for changes in relative abundances of
mRNAs spliced from the same primary transcript between control
and TIA1 or TIAR-silenced conditions, which is detected as
alternative splicing. Thus, Cufflinks discriminates between tran-
scriptional and post-transcriptional processing ([29] and Fig. 1A).
Using Venn diagrams, a summary of the number of shared and
differential expressed genes (DEGs), genes with isoforms (splicing
data filtered by gene name), RNA isoforms (splicing data filtered
by NM identifier), promoters and micro(mi)RNAs is shown in
Fig. 1D–H and Fig. S4–S6. Collectively, these results indicate that
TIA1 and/or TIAR regulate both specific and overlapping aspects
of the human transcriptome, suggesting that their functional roles
can be redundant, additive and/or independent, in agreement
with previous findings [22,24,25,28,44].
Classification and cluster analysis of genes, RNAs and
promoters identified by RNA-seq
As a first attempt to understand the functional relevance of
differentially expressed up- and down-regulated genes, isoforms
and promoters in TIA or TIAR-silenced HeLa cells, Gene
Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes
(KEGG) database analysis was performed. GO and KEGG
analysis were able to identify the main categories of biological
processes and pathways of DEGs controlled by TIA1 and TIAR
(P,0.05). GO categories related to regulation of DNA transcrip-
tion, signal transduction, multicellular organismal development,
cell adhesion and differentiation, cell proliferation, apoptosis and
nervous system were among the enriched categories in both up-
and down-regulated genes obtained through silencing of TIA1 or
TIAR (Fig. 2A, C, E, and G and Fig. S4–S6). KEGG database
analysis, integrating individual components into unified pathways,
was used to identify the enrichment of specific pathways in
functionally-regulated gene and RNA groups. The results showed
that several KEGG pathways were significantly enriched (P,0.05)
in both up- and down-regulated genes, including pathways
involved in focal adhesion, cancer, axon guidance, extracellular
matrix components (EMC)-receptor interaction, MAPK signalling
and regulation of actin cytoskeleton (Fig. 2B, D, F, and H and Fig.
S4–S6). GO categories related to alternative promoter usage
involved biological processes associated with DNA transcription,
cell differentiation and cycle, signal transduction and metabolism
(Fig. 2I and J and Fig. S4–S6). Collectively, these results suggest
that both TIAR and TIA1 modulate specific and overlapping
aspects of the transcriptome (DEGs, alternative splicing and
promoters) related to the extracellular environment and signal
transduction pathways, which could contribute to the cell
proliferation and differentiation phenotypes described in TIA1
and/or TIAR-knocked down HeLa cells [19,25].
Microarray analysis and functional categories
To validate genes and regulatory trends found after silencing
both TIA proteins, we used genome-wide expression microarrays.
This yielded a set of differentially expressed genes in TIA1 and
TIAR-silenced HeLa cells: 251 genes were up-regulated and 173
genes were down-regulated by more than 1.5-fold (FDR RP,
0.05) (Fig. 3A and Fig. S7). GO and KEGG database analysis of
the up- and down-regulated genes showed significant enrichments
in genes associated with signal transduction, cell and focal
adhesion, multicellular organismal development and the nervous
system (Fig. 3B and C). A comparison of the results obtained from
RNA-seq and genome-wide analysis revealed the superior power
of massive-RNA sequencing (Fig. 3D), suggesting that our
understanding of transcriptional complexity linked to TIA proteins
is far from complete.
Validation of RNA-seq and mRNA array-predicted
changes by QPCR
To validate previous results on identified genes and their
relative expression levels, several up- and down-regulated mRNAs
were confirmed by quantitative RT-PCR (QPCR) analysis (Fig.
S8). As shown in Fig. 4, the results obtained by quantitative
amplification (Fig. 4A) were fully consistent with the data observed
by hybridization using microarrays, and the relative fold changes
in individual massive RNA sequencing for TIA1 or TIAR
(Fig. 4B).
Knockdown of TIA proteins results in increased cell
adhesion rates
As shown in Fig. 2, 3 and S4–S7, GO and KEGG analysis
suggested a long-term role for TIA1 proteins in molecular events
linked with cell adhesion. To validate these results at the functional
level, we examined the cell adhesion potential of HeLa cells with
reduced TIA1 and TIAR expression. As shown in Fig. S9, the
TIA Proteins Modulate Transcriptomic Heterogeneity and Dynamics
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reduction of TIA1 plus TIAR expression in HeLa cells resulted in
an increased cell adhesion capacity compared with control HeLa
cells. Indeed, measurement of metabolic activity by methyl
thiazolyl tetrazolium (MTT) assay, support a role for TIA proteins
in the regulation and/or modulation of cell-substratum adhesion.
This capacity, associated with the reduction of the levels of TIA
proteins, was stimulated with phorbol 12-myriaste 13-acetate
(PMA) in control HeLa cells after 4 hours of incubation (Fig. S9).
Furthermore, as shown in Fig. S10, the sustained reduction of
TIA1 and/or TIAR could promote a significant and reproducible
induction (2- to 16-fold) of a luciferase construct under the control
of COL1A2 human promoter sequences [43], suggesting that
diminished expression of TIA proteins deregulates the basal
transcriptional activity of this promoter. Taken together, these
observations may suggest that the gene expression patterns
detected in TIA1/TIAR-knocked down HeLa cells might be the
result of an overlapping regulation, implying the involvement of
several molecular events regulated and/or modulated by these
multifunctional proteins on cell adhesion and extracellular matrix
components.
Discussion
Polyvalent TIA proteins have pleitropic effects on RNA biology
and function as cell sensors to sustain homeostasis and facilitate
adaptation, survival or death responses to a great variety of
stressing conditions involving environmental and epigenetic
challenges in the short- and long-term [19,22–25,28,44]. To do
this, these multifunctional regulators orchestrate transcriptome
dynamics associated with transcriptional and/or post-transcrip-
tional regulatory programs, which regulate and/or modulate
molecular events and processes with relevant biological implica-
tions in cellular phenotypes and behaviours related with apoptosis,
inflammation, viral infections, embryogenesis and oncogenesis
[13–25]. Through genome-wide expression profiling approaches,
we have identified many important genes/RNAs and have made a
preliminary attempt to construct the regulatory pathways impli-
cated in TIA-downregulated HeLa cells. Herein, we report that
sustained TIA down-regulation has a functional impact on a
human transcriptome associated to differentially-expressed genes
and RNA isoforms generated by alternative splicing and/or
promoter usage which are prevalently linked to gene categories
related with focal/cell adhesion, extracellular matrix, membrane
and cytoskeleton dynamics.
Cancer cells often exhibit hyperactive signalling pathways
activated by membrane components. Cell and focal adhesions
and cytoskeleton dynamics provide contact between neighbouring
cells or between a cell and the extracellular matrix and, as such,
play essential roles in the regulation of migration, proliferation,
differentiation and apoptosis, and also tumorigenesis [45]. The
reduction of TIA expression results in altered expression of
extracellular matrix, membrane and cytoskeleton components and
also signal transduction genes [23,24,44,46], thus providing an
Figure 2. Top-five categories of biological processes and pathways associated with TIA1 or TIAR-silenced HeLa cells. (A–D)
Histograms of the distribution of up- (red) and down- (green) regulated genes using the Gene Ontology (GO) (A and C) and Kyoto Encyclopedia of
Genes and Genomes (KEGG) (B and D) databases (P,0.05) in TIA1 (A and B) or TIAR (C and D)-silenced HeLa cells. (E–H) Histograms of the
distribution of up- (red) and down- (green)-regulated RNA isoforms using the GO (E and G) and KEGG (F and H) databases (P,0.05) in TIA1- (E and F)
or TIAR- (G and H) silenced HeLa cells. (I and J) Histograms of the gene distribution of alternative promoter usage in the GO database (P,0.05) in
TIA1- (I) or TIAR- (J) silenced HeLa cells.
doi:10.1371/journal.pone.0113141.g002
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additional molecular basis for the observation that sustained TIA
down-regulation contributes to the deleterious phenotypes ob-
served in HeLa cells lacking TIA proteins [23–25]. Notably, the
down-signature enriched category included the focal and cell
adhesion components (as for example, ALCAM, AMBP, CD9,
DMKN, FLRT2, FOLR1, ITGA6, L1CAM, NOTCH3, OLR1,
PCDHA1, PPP2R5C, RSPO3, TNNC1 and TSPAN8). These
components play important roles in cell biology, and phenotypes
linked to transformed cancer cells [45,47,48]. Moreover, genes in
the more significantly up-regulated network module included
collagens (as for example, COL1A1, COL1A2, COL3A1 and
COL8A1) and extracellular matrix-related components (as for
example, CD36, CFH, CGA, FBN2, IGFBP7, LGALS8, LOX,
PDGFC and TNC). These observations strengthen the association
of this gene subset with most transformed cell phenotypes and
relate it to cell growth and survival responses [47,48]. The effects
of TIA expression on extracellular matrix and focal/cell adhesion
phenomena would depend on how transcriptome dynamics are
integrated in a given cell type and physiological context, and could
have significant implications in inflammatory diseases and cancer
progression [17,19,22–25,49,50].
TIA proteins are able to bind the same sequence motifs and sites
on some human RNAs [12–16], and they can regulate and/or
modulate some overlapping aspects of the human transcriptome
[12–16]. A previous TIA-iCLIP analysis in HeLa cells showed that
the highest enrichment density of cDNAs were seen in introns and
39-UTRs [12]. These observations are consistent with the role of
TIA proteins in pre-mRNA splicing, localization, stability and/or
translational regulation, via binding U-, C- and AU-rich sequence
elements located at the 59 spliced sites and the 59 and 39-UTRs,
respectively [9–21]. It is interesting to note that no overlap was
observed between gene targets reported to be regulated by TIA1
at the translational level [13], and genes predicted in silico to be
regulated by TIA1/TIAR at the alternative pre-mRNA splicing
level [51]. This observation suggests that TIA proteins could be
regulating and/or modulating distinct subsets of genes at the
splicing and translational levels. The TIA-iCLIP data have
expanded the total number of post-transcriptional events and
associated gene functions that could be predicted to be regulated
by TIA proteins. Thus, the estimated frequency of cellular events
regulated by TIA1/TIAR via specific-sequences motifs might be
approximately 20–30% [3,4,12,51].
Tumorigenesis is caused both by genetic and epigenetic events.
The progressive acquisition of mutations in oncogenes or tumor-
suppressor genes might act in concert with epigenetic events, such
as functional down-regulation of TIA proteins, to give cells a
competitive growth advantage. TIA1 and TIAR genes are
mutated [52] and down-regulated [18,21,25,44,49,50] in several
types of human cancers. In human transformed cells, TIA proteins
regulate the transcription, alternative splicing, stability and/or
translation of many target genes associated with tumor develop-
ment and progression, involving the control of cell proliferation,
Figure 3. Characterization by genome-wide profiling of the transcriptome associated with TIA-silenced HeLa cells. (A) MA plot
representation of the distribution of up- (spots in red) and down- (spots in green) regulated RNAs (–1.5$ fold-change #1.5; FDR,0.05) in TIA1 and
TIAR-silenced versus control HeLa cells. (B and C) Histograms of the distribution of up- (red) and down- (green) regulated genes using the GO (B) and
KEGG (C) databases (P,0.05) in TIA1 and TIAR-silenced HeLa cells. (D) Comparison between RNA-seq and genome-wide array data. Venn diagrams
depicting the numbers of genes that were up- (red) and down- (green) regulated as well as those shared in TIA1 or/and TIAR-knocked down HeLa
cells.
doi:10.1371/journal.pone.0113141.g003
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apoptosis, angiogenesis, invasion, metastasis, evasion of immune
recognition and metabolic reprogramming [13–25]. Thus, the
sustained reduction of TIA proteins could facilitate the acquisition
of oncogenic phenotypes [25] characterized by severe alterations
in cell proliferation/growth, invasion and morphology, via
modulation of several gene expression layers involving changes
to global and specific translational rates of cell-cycle G2/M phase
transition and DNA replication/repair factors encoding mRNAs
[24] as well as actin [23] and tubulin [46] cytoskeletons, together
with transcriptome dynamics linked to extracellular matrix, focal/
cell adhesion and membrane regulatory events. Thus, prolonged
TIA knockdown may lead to cell proliferation and neoplastic
growth by simultaneously activating translation of mRNAs that
encode proteins involved in cell cycle progression and cell
dynamics. These findings also suggest cooperation of transcrip-
tomic and translational programs that underpin prevalent
biological effects on TIA-associated gene expression networks.
This cellular and molecular scenario could contribute to the
different phenotypes observed in TIA-knocked down HeLa cells.
Therefore, our observations support the idea that these proteins
might function as cell growth and tumor suppressor genes, through
the regulation and/or modulation of many RNAs which are
targeted by transcriptional and post-transcriptional regulatory
events. However, further investigation is required to discern the
cellular and molecular mechanisms underlying TIA protein
control/modulation of gene expression. Results from these studies
could potentially give insights into the differential gene networks
that contribute to cell phenotypes observed in the absence of these
regulators, both at short- and long-term, in homeostasis and
environmental stress conditions.
Supporting Information
Figure S1 shRNA-mediated knockdown of TIA1 and
TIAR in HeLa cells. HeLa cells silenced for expression of TIA1,
TIAR or HuR were stained with anti-TIA1, anti-TIAR, anti-HuR
and anti-a-tubulin antibodies and were visualized by confocal
microscopy, as described [23,24]. The scale bar is 10 mm.
(PDF)
Figure S2 Metrical data of massive-scale poly(A+) RNA
sequencing analysis.
(XLS)
Figure S3 Summary of contig distribution on human
chromosomes in control, TIA1 and TIAR-silenced HeLa
cells. The RNA-seq read density along the lengths of the human
chromosomes is illustrated. Each bar represents the log2 of the
frequency reads plotted against chromosome coordinates. RNA-
seq data were mapped to the UCSC Human genome build 19.
The RNA map corresponding to RNA binding proteins TIA1 and
TIAR is included at the bottom. The results were adapted using
the TIA1 and TIAR in vivo ultraviolet (UV)-crosslinking and
immunoprecipitation (iCLIP) analysis provided by the Ule
laboratory [12].
(PDF)
Figure 4. Validation of RNA-seq and microarray predicted changes. (A) Quantification of relative expression levels of indicated genes by
qPCR. (B) RNA-seq mapping to the UCSC reference genome (hg19) of the genes indicated in control and TIA1 or TIAR-knocked down HeLa cells. A
schematic representation of every gene analyzed is shown at the bottom. (C) Summary of the molecular and cellular events associated with
transcriptome dynamics in TIA-downregulated HeLa cells.
doi:10.1371/journal.pone.0113141.g004
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Figure S4 List of massive sequencing-predicted genes in
TIA1-silenced HeLa cells. Functional clusters based on
Gene Ontology (GO) and Kyoto Encyclopedia of Genes
and Genomes (KEGG) databases.
(XLS)
Figure S5 List of massive sequencing-predicted genes in
TIAR-silenced HeLa cells. Functional clusters based on
GO and KEGG databases.
(XLS)
Figure S6 List of shared and contrasting expressed
genes and their GO/KEGG analysis from TIA1 and
TIAR-silenced HeLa cells.
(XLS)
Figure S7 List of differentially expressed genes in TIA-
silenced HeLa cells by microarray analysis. Functional
clusters based on GO and KEGG databases.
(XLS)
Figure S8 List of primer pair sequences used in QPCR
analysis.
(XLS)
Figure S9 Effect of TIA1 and TIAR knockdown on cell
adhesion. Cell adhesion of control and TIA-knocked down
HeLa cells was assessed using either plastic, BSA-coated or
collagen-coated plates. Cells were seeded and processed as
indicated. Thereafter, the number of adhered cells was quantified
by measuring the conversion of MTT into DMSO-soluble
formazan by living cells, at 570 nm. The represented values were
normalized and expressed relative to control values (whose value
was fixed arbitrarily to 1 and are mean 6 standard error of the
mean (SEM) of at least two independent experiments.
(PDF)
Figure S10 Effect of TIA1 and/or TIAR knockdown on
transcriptional activation of the COL1A2 gene promoter.
Schematic representation of the COL1A2 human gene promoter
is shown. Cis-acting consensus sequences are represented by boxes.
Control and TIA1 and/or TIAR-silenced HeLa cells were
transiently cotransfected with the COL1A2 promoter-driven
firefly luciferase construct together with a GFP-expressing plasmid
(used as a transfection control). The represented values –the ratio
between luciferase relative light units (RLU)/GFP expression
measured by Western blot– were normalized and expressed
relative to the control sample, whose value was fixed arbitrarily to
1, and are mean 6 SEM of at least two independent experiments.
(PDF)
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